期刊文献+

p53、一氧化氮合酶及血管内皮生长因子在子宫颈癌的表达及意义 被引量:3

Expression of p53,nitric oxide synthase and VEGF in cervical carcinoma and its clinical significance
原文传递
导出
摘要 目的探讨p53、一氧化氮合酶(NOS)和血管内皮生长因子(VEGF)的表达与宫颈癌内血管生成和预后的关系。方法采用免疫组化染色(SP法)检测49例子宫颈癌的p53、iNOS、eNOS及VEGF,并于临床病理及预后指标进行分析同时进行随访。结果宫颈癌组织中p53、iNOS、eNOS及VEGF阳性表达分别是59.2%、71.4%、57.1%和49.0%。p53、NOS和VEGF均与宫颈癌临床分期、术后生存时间有密切关系(P<0.05),但与组织学类型无关(P>0.05);iNOS与宫颈癌病理分级有密切关系;p53、NOS与VEGF的表达呈正相关(P<0.05)。结论p53、NOS及VEGF的表达水平与宫颈癌的进展、术后生存时间有密切关系,提示p53、NOS及VEGF可作为患者预后评估的重要指标。 Objective To study the expression of p53, nitric oxide synthase (NOS), vascular endothelial growth factor(VEGF) and their relation with angiogenesis and prognosis in cervical carcinoma. Methods The expressions of p53,iNOS, eNOS and VEGF were determined in 49 cases of cervical carcinoma with immunohistochemieal method(SP method), and the results were compared with pathology, and the cases were followed-up. Results The expression rates of cervical carcinoma of p53, iNOS, eNOS and VEGF were 59.2 %, 71.4 %, 57. 1% and 49.0 % ,respectively. They were not associated with histological type( P 〉 0.05 ), but significantly correlated to FIGO stages and the postoperative survival data( P 〈 0.05). iNOS were related to grading of cervical carcinoma. Conclusion The expression of p53, NOS and VEGF has close relation to angiogenesis, growth,invasion in cervical carcinoma. They may be accepted as important markers to evaluate the prognosis of cervical carcinoma.
作者 李洪钧 李红
出处 《中国基层医药》 CAS 2006年第4期645-646,共2页 Chinese Journal of Primary Medicine and Pharmacy
关键词 宫颈肿瘤 蛋白质P53 一氧化氮合酶 血管内皮生长因子类 Cervix neoplasms Protein p53 Nitric-oxide synthase Vascular endothelial growth factors
  • 相关文献

参考文献7

二级参考文献32

  • 1[1]Suschek CV, Krischel V, Bruch-Gerharz D, et al. Nitric oxide fully protects against UVA-induced apoptosis in tight correlation with bcl-2 up-regulation[J]. J Bio Chem, 1999,274(10):6130-6137. 被引量:1
  • 2[2]Knowles RG and Moncada S. Nitric oxide synthases in mammals[J]. Biochem J. 1994,298(pt 2):249-258. 被引量:1
  • 3[3]Cobbs CS, Brenman JE,Aldape KD,et al. Expression of nitric oxide synthase in human central nervous system tumors[J]. Cancer Res, 1995,55(4):727-730. 被引量:1
  • 4[4]Hamaoka R, Yaginuma Y, Takahashi Y,et al. Different expression patterns of nitric oxide synthase isozymes in various gynecological cancers[J]. J Cancer Res Clin Oncol, 1999,125(6):321-326. 被引量:1
  • 5[5]Reveneau S, Amould L, Jolimoy G, et al. Nitric oxide synthase in human breast cancer is associated with tumor grade, proliferation rate, and expression of progesterone receptors[J]. Lab Invest, 1999,79(10):1215-1225. 被引量:1
  • 6[6]Fujimoto H, Ando Y, Yamashita T, et al. Nitric oxide synthase activity in human lung cancer[J]. Jpn J Cancer Res, 1997,88(12):1190-1198. 被引量:1
  • 7[7]Ambs S, Merriam WG, Bennett WP, et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tmor angiogenesis and colon cancer progression[J]. Cancer Res, 1998,58(2):334-341. 被引量:1
  • 8[8]Klotz T, Bloch W, Jacobs G, et al. Immunolocalization of inducible and constitutive nitric oxide synthase in human bladder cancer[J]. Urology, 1999,54(3):416-419. 被引量:1
  • 9[9]Gallo O, Masini E, Morbidelli L, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer[J]. J Natl Cancer Inst, 1998,90(8):587-596. 被引量:1
  • 10[10]Rajnakova A, Goh PM, Chan ST, et al. Expression of differential nitric oxide synthase isoforms in human normal gastric mucosa and gastric cancer tissue[J]. Carcinogenesis, 1997,18(9):1841-1845. 被引量:1

共引文献7

同被引文献18

  • 1张文淼,王群姬,帅茨霞,朱华.FHIT基因表达异常或缺失与宫颈癌前病变及宫颈癌的关系[J].温州医学院学报,2005,35(1):31-33. 被引量:5
  • 2张惠娇,李玲,沈洪武,吴文乔.C-erbB-2、P53和Ki-67在宫颈癌的表达及其临床意义[J].齐齐哈尔医学院学报,2006,27(2):131-133. 被引量:7
  • 3周蓓蓓,董春雷,周晨,蒋鹏程,孔颖泽.检测血清Scc-Ag对子宫颈癌放射治疗和随访的意义[J].现代肿瘤医学,2006,14(7):880-881. 被引量:1
  • 4王春晓,佟林林,孙淑娥.宫颈癌流行病学调查和筛查研究进展[J].齐齐哈尔医学院学报,2007,28(7):826-830. 被引量:30
  • 5Nawata S, Sueoka K, Fukushima C, et al. Biological function and clinical significance of a serological tumor marker, squamous cell carcinoma antigen in squamous cell carcinoma of the uterine cervix[J]. Tumor Biology, 2008,29( 1 ) : 21-24. 被引量:1
  • 6Ohta M, Inane H, Cottjcelli WG, et al. The FHIT gene-spanning the chromosome 3p14.2 fragile site and renal carcinoma-associat- ed ( 3:8 ) breakpoint,is abnormal in digestive tract'cancers. Cell, 1996,84(4) :587-597. 被引量:1
  • 7Sard L, Accomero P, Tomielli S, et al. The tumor 2suppressor gene FHIT is involved in the regulation of a poptosis and in cell cycle control. Proe Natl Acad Sci USA, 1999,96 ( 15 ) : 8489- 8492. 被引量:1
  • 8Ji L, Fang B, Yen N, et al. Induction and tumor growth by adeno- virus of a poptosis and inhibition of tumor igcnieity veetor media- ted fragile histidinetriad (FHIT) gene over expression. Cancer Res, 1999,59(14) :3333-3339. 被引量:1
  • 9Vecchione A,Zanesi N,Trombetta G,et al. Cervical dysplasia ploidy- an human papilloma virus statis correlate with loss of FHIT expre- ssion. Clin Cancer Res,2001,7(5) :1306-1312. 被引量:1
  • 10Butler D, Collins C, Mabruk M, et al. Deletion of the FHIT gene in neoplastie and invasive cerviea lesions is related to high-risk HPV in fection but is independent of histopathological features. J Pathol, 2000,192 (4) : 502-510. 被引量:1

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部